Journal
DIABETES OBESITY & METABOLISM
Volume 10, Issue 6, Pages 515-U8Publisher
WILEY
DOI: 10.1111/j.1463-1326.2007.00838.x
Keywords
exendin-4; GLP-1; type 2 diabetes; pancreatic islets
Categories
Ask authors/readers for more resources
Exendin-4 is a dipeptidyl peptidase IV (DPP-IV)-resistant glucagon-like peptide1 (GLP-1) mimetic and its synthetic counterpart, exenatide, is being used in the therapy of type 2 diabetes (T2DM). No information, however, is currently available as for the direct action of exendin-4 on human T2DM islets. In the present study, we exposed pancreatic islets prepared from non-diabetic and T2DM subjects to exendin-4 for 48 h and found that the compound had several, direct beneficial actions on insulin secretion and the expression of genes involved in beta-cell function and differentiation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available